These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 21851213

  • 21. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
    Rhee HK, Yoo JH, Lee E, Kwon YJ, Seo HR, Lee YS, Choo HY.
    Eur J Med Chem; 2011 Sep; 46(9):3900-8. PubMed ID: 21704436
    [Abstract] [Full Text] [Related]

  • 22. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J, Ren H, Zhao M, Chong Y, Zhao W, He Y, Zhao Y, Zhang H, Qi C.
    Eur J Med Chem; 2017 Sep 29; 138():669-688. PubMed ID: 28711702
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and evaluation of 4-anilinoquinazoline bioisosteres as potential anti-breast cancer agents.
    El-Ansary AK, Kamal AM, Al-Ghorafi MA.
    Eur J Med Chem; 2014 Oct 30; 86():202-10. PubMed ID: 25151582
    [Abstract] [Full Text] [Related]

  • 24. Design and synthesis of a quinazolinone natural product-templated library with cytotoxic activity.
    Liu JF, Kaselj M, Isome Y, Ye P, Sargent K, Sprague K, Cherrak D, Wilson CJ, Si Y, Yohannes D, Ng SC.
    J Comb Chem; 2006 Oct 30; 8(1):7-10. PubMed ID: 16398546
    [No Abstract] [Full Text] [Related]

  • 25. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K, Ibrahim MK, Alesawy MSI, Eissa IH.
    Bioorg Med Chem; 2021 Jan 15; 30():115958. PubMed ID: 33360576
    [Abstract] [Full Text] [Related]

  • 26. New derivatives of quinazoline and 1, 2-dihydroquinazoline n3-oxide with expected antitumor activity.
    Mikiciuk-Olasik E, Baszczak-Swiatkiewiz K, Zurek E, Krajewska U, Rózalski M, Kruszyński R, Bartczak TJ.
    Arch Pharm (Weinheim); 2004 May 15; 337(5):239-46. PubMed ID: 15095417
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB, Wang XL, Liu W, Yang YS, Tang JF, Zhu HL.
    Bioorg Med Chem; 2012 Nov 01; 20(21):6356-65. PubMed ID: 23018096
    [Abstract] [Full Text] [Related]

  • 29. Design, synthesis, and biological evaluation of new diaminoquinazolines as β-catenin/Tcf4 pathway inhibitors.
    Mao Y, Lin N, Tian W, Han X, Han X, Huang Z, An J.
    J Med Chem; 2012 Feb 09; 55(3):1346-59. PubMed ID: 22229647
    [Abstract] [Full Text] [Related]

  • 30. Design, synthesis and cytotoxic activity of novel spin-labeled rotenone derivatives.
    Liu YQ, Ohkoshi E, Li LH, Yang L, Lee KH.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):920-3. PubMed ID: 22204911
    [Abstract] [Full Text] [Related]

  • 31. Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents.
    Cai J, Sun M, Wu X, Chen J, Wang P, Zong X, Ji M.
    Eur J Med Chem; 2013 May 15; 63():702-12. PubMed ID: 23567960
    [Abstract] [Full Text] [Related]

  • 32. Synthesis, biological evaluation and docking studies of 4-amino-tetrahydroquinazolino[3,2-e]purine derivatives.
    Verones V, Flouquet N, Farce A, Carato P, Leonce S, Pfeiffer B, Berthelot P, Lebegue N.
    Eur J Med Chem; 2010 Dec 15; 45(12):5678-84. PubMed ID: 20884092
    [Abstract] [Full Text] [Related]

  • 33. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
    Lv Z, Zhang Y, Zhang M, Chen H, Sun Z, Geng D, Niu C, Li K.
    Eur J Med Chem; 2013 Sep 15; 67():447-53. PubMed ID: 23920246
    [Abstract] [Full Text] [Related]

  • 34. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
    Kolb S, Goddard ML, Loukaci A, Mondésert O, Ducommun B, Braud E, Garbay C.
    Eur J Med Chem; 2010 Mar 15; 45(3):896-901. PubMed ID: 19969400
    [Abstract] [Full Text] [Related]

  • 35. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives.
    Cai J, Zhang S, Zheng M, Wu X, Chen J, Ji M.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):806-10. PubMed ID: 22217877
    [Abstract] [Full Text] [Related]

  • 36. Selenium-containing naphthalimides as anticancer agents: design, synthesis and bioactivity.
    Zhao L, Li J, Li Y, Liu J, Wirth T, Li Z.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2558-63. PubMed ID: 22436386
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase I inhibitors with molecular modeling.
    Le TN, Yang SH, Khadka DB, Van HT, Cho SH, Kwon Y, Lee ES, Lee KT, Cho WJ.
    Bioorg Med Chem; 2011 Jul 15; 19(14):4399-404. PubMed ID: 21684168
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents.
    Jiang N, Zhai X, Zhao Y, Liu Y, Qi B, Tao H, Gong P.
    Eur J Med Chem; 2012 Aug 15; 54():534-41. PubMed ID: 22727449
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and antitumor activity of inositol phosphotriester analogues.
    Song F, Zhang J, Zhao Y, Chen W, Li L, Xi Z.
    Org Biomol Chem; 2012 May 14; 10(18):3642-54. PubMed ID: 22469854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.